Browse > Article
http://dx.doi.org/10.4062/biomolther.2011.19.2.218

Spinach Saponin-Enriched Fraction Inhibits Platelet Aggregation in cAMP- and cGMP-Dependent Manner by Decreasing TXA2 Production and Blood Coagulation  

Cho, Hyun-Jeong (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University)
Choi, Sun-A (Department of Biomedical Laboratory Science, College of Biomedical Science, Inje University)
Kim, Chun-Gyu (Department of Pharmaceutical Engineering, College of Engineering, Inje University)
Jung, Tae-Sung (Department of Pharmacy, Kungsung University)
Hong, Jeong-Hwa (School of Food and Life Science, College of Biomedical Science and Engineering, Inje University)
Rhee, Man-Hee (College of Veterinary Medicine, Kyungpook National University)
Park, Hye-Jin (Department of Bioscience and Biotechnology, Konkuk University)
Park, Hwa-Jin (Department of Biomedical Laboratory Science, College of Biomedical Science, Inje University)
Publication Information
Biomolecules & Therapeutics / v.19, no.2, 2011 , pp. 218-223 More about this Journal
Abstract
In this study, we investigated the effect of spinach saponin-enriched fraction (SSEF) on collagen (10 ${\mu}g/ml$)-stimulated platelet aggregation. SSEF inhibited collagen-induced platelet aggregation, and which was involved in the inhibition of thromboxane $A_2$ ($TXA_2$) production, an intracellular $Ca^{2+}$-agonist as an aggregation-inducing autacoidal molecule. In addition, SSEF significantly increased the formation of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), intracellular $Ca^{2+}$-antagonists as aggregation-inhibiting molecules, in collagen-stimulated platelets. These results suggest that SSEF might inhibit $Ca^{2+}$-elevation and $TXA_2$ formation by increasing the production of $Ca^{2+}$-antagonistic molecules cAMP and cGMP. These mean that SSEF is a potent inhibitor of collagen-stimulated platelet aggregation. On the other hand, prothrombin time (PT) and activated partial thromboplastin time (APTT) were potently prolonged by SSEF. These findings suggest that SSEF prolongs the internal time between the conversion of fibrinogen to fibrin. Accordingly, our data demonstrate that SSEF may be a crucial tool for a negative regulator during platelet activation and blood coagulation on thrombotic diseases.
Keywords
Spinach saponin-enriched fraction (SSEF); Platelet aggregation; Blood coagulation; Thrombotic diseases;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By Web Of Science : 4  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Kimura, Y., Okuda, H. and Arichi, S. (1988) Effects of various ginseng saponins on 5-hydroxytryptamine release and aggregation in human platelets. J. Pharm. Pharmacol. 40, 838-843.   DOI
2 Lomnitski, L., Bergman, M., Nyska, A., Ben-Shaul, V. and Grosman, S. (2003) Composition, effi cacy, and safety of spinash extracts. Nutr Cancer. 46, 222-231.   DOI
3 Moncada, S. and Vane, J. R. (1978) Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane $A_2$ and prostacyclin. Pharmacol. Rev. 30, 293-331.
4 Moon, M. K., Ahn, J. Y., Kim, S., Ryu, S. Y., Kim, Y. S. and Ha, T. Y. (2010) Ethanol extract and saponin of Platycodon grandifl orum ameliorate scopolamine-induced amnesia in mice. J. Med. Food. 13, 584-588.   DOI
5 Nishikawa, M., Tanaka, T. and Hidaka, H. (1980) $Ca^2+$-calmodulindependent phosphorylation and platelet secretion. Nature 287, 863-865.   DOI
6 Podolak, I., Galany, A. and Sobolewska, D. (2010) Saponins as cytotoxic agents: a review. Phytochem. Rev. 9, 425-474.   DOI
7 Prinz-Langenohl, R., Bronstrup, A., Thorand, B., Hages, M. and Pietrzik, K. (1999) Availability of food folate in humans. J. Nutr. 129, 913-916.
8 Sani, H. A., Rahat, A., Ismail, M., Rosli, R. and Endrini, S. (2004) Potential anticancer effect of red spinach (Amaranthus gangeticus) extract. Asia Pac. J. Clin. Nutr. 13, 396-400.
9 Sano, Y., Sato, K., Uchida, M. and Murata, M. (2003) Blood coagulation fibrinolysis of rats fed fi sh oil: reduced coagulation factors especially involved in intrinsic pathway and increased activity of plasminogen activator inhibitor. Biosic. Biotechnol. Biochem. 67, 2100-2105.   DOI
10 Cho, H. J., Ham, H. S., Lee, T. K., Jung, Y. J., Choi, S. A., Kang, H. C. and Park, H. J. (2004) Inhibitory effect of cordycepin on human platelet aggregation. J. Biomed. Lab. Sci. 10, 1-8.   과학기술학회마을
11 Davie, E. W. and Ratnoff, O. D. (1964) Waterfall sequence for intrinsic blood clotting. Science 145, 1310-1312.   DOI
12 Dogne, J. M., de Leval, X., Hanson, J., Frederich, M., Lambermont, B., Ghuysen, A., Casini, A., Masereel, B., Ruan, K. H., Pirotte, B. and Kolh, P. (2004) New developments on thromboxane and prostacylcin modulators part I: thromboxane modulators. Curr. Med. Chem. 11, 1223-1241.   DOI   ScienceOn
13 Edwards, A. J., You, C. S., Swanson, J. E. and Parker, R. S. (2001) A novel extrinsic reference method for assessing the vitamin A of plant foods. Am. J. Clin. Nutr. 74, 348-355.
14 Furie, B. and Furie, B. C. (1988) The molecular basis of blood coagulation. Cell 53, 505-518.   DOI
15 Gorman, R. R., Johnson, R. A., Spilman, C. H. and Aiken, J. W. (1983) Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate. Prostaglandins 26, 325-342.   DOI
16 Hamberg, M., Svensson, J. and Samuelsson, B. (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. 72, 2994-2998.   DOI
17 Hanson, J., Rolin, S., Reynaud, D., Qiao, N., Kelley, L. P., Reid, H. M., Valentin, F., Tippins, J., Kinsella, B. T., Masereel, B., Pace-Asciak, C., Pirotte, B. and Dogne, J. M. (2005) In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl] urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist. J. Pharmacol. Exp. Ther. 313, 293-301.
18 Bergman, M., Varshavsky, L., Gottlieb, H. E. and Grosman, S. (2001) The antioxidant activity of aqueous spinach extract: chemical identifi cation of activity fractions. Phytochemistry 58, 143-152.   DOI
19 Afolayan, A. J. and Jimoh, F. O. (2009) Nutritional quality of some wild leafy vegetables in South Africa. Intl. J. Food Sci. Nutr. 60, 424-431.   DOI
20 Akoum, A., Josefonvicz, J. and Sigot, M. (1990). Anticoagulant activity of a bacterial glycopeptide. Thromb. Res. 60, 9-18.   DOI
21 Cattaneo, M., Tenconi, P. M., Lecchi, A. and Mannucci, P. M. (1991) In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Thromb. Res. 62, 717-724.   DOI
22 Charo, I. F., Feinman, R. D. and Detwiler, T. C. (1997) Interrelations of platelet aggregation and secretion. J. Clin. Invest. 60, 866-873.
23 Tsai, Y. C., Lin, C. L. and Chen, B. H. (2010) Preparative chromatography of flavonoids and saponins in Gynostemma pentaphyllum and their antiploliferation effect on hepatoma cell. Phytomedicine. 18, 2-10.   DOI
24 Schwartz, S. M., Heinmark, R. L. and Majesky, M. W. (1990) Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70, 1177-1209.
25 Schwarz, U. R., Walter, U. and Eigenthaler, M. (2001) Taming platelets with cyclic nucleotides. Biochem. Pharmaco. 62, 1153-1161.   DOI
26 Sinha, A. K., Rao, A. K., Willis, J. And Colman, R. W. (1983) Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa. Proc. Natl. Acad. Sci. USA. 80, 6086-6090.   DOI
27 Stegmeier, K., Pill, J., Muller-Beckmann, B., Schmidt, F. H., Witte, E. C., Wolff, H. P. and Patscheke, H. (1984) The pharmacological profi le of the thromboxane A2 antagonists BM 13.177. A new antiplatelet and anti-thrombotic drug. Thromb. Res. 35, 379-395.   DOI
28 Sudo, T., Ito, H. and Kimura, Y. (2003) Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the antiplatelet drug, cilostazol, in platelets. Platelets 14, 381-390.   DOI
29 Jang, E. K., Azzam, J. E., Cickinson, N. T., Davidson, M. M. and Haslam, R. J. (2002) Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprusside. Br. J. Haematol. 117, 664-675.   DOI